log-in

About Us / Announcements

Contact a Specialist

About Us

News & Press Releases

3/5/2014

Research by Structural Genomics Consortium and DiscoveRx Points to New Multi-Targeting Approaches to Cancer Therapy

Joint Publication Identifies Clinical Kinase Inhibitors that Potently Cross React with Bromodomain Epigenetic Reader Proteins

11/20/2013

Leading Drug Discovery Scientists Leverage PathHunter® Arrestin Technology for Discovery of Novel GPCR Drugs

10/22/2013

DiscoveRx Expands into Immunology Market with Launch of New Human Primary Cell-Based T Cell Autoimmune Panel

9/12/2013

DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research

11/7/2012

Discoverx Corporation Acquires BioSeek® - Adds Primary Cell Assays to Portfolio of Drug Discovery Solutions

6/5/2012

DiscoveRx Breaks the Barriers of Conventional Cell-Based Screening With Launch of a Powerful New InCELL Hunter™ Platform

5/16/2012

DiscoveRx Introduces a High-Throughput Biochemical Screening Platform for Bromodomain Epigenetic "Reader" Proteins

5/1/2012

Comprehensive PathHunter® Assay Portfolio Driving Antibody Therapeutic Discovery Programs

2/3/2012

DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs

11/29/2011

Compugen and DiscoveRx® Form Collaboration to Commercialize Novel Peptide Ligands for GPCR Drug Targets

Displaying results 21-30 (of 45)

|< < 1 - 2 - 3 - 4 - 5 > >|